Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Angiosarcoma
• Epithelioid Sarcoma
• Fibrosarcoma
• Leiomyosarcoma
• Liposarcoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12